- Home
- APLT vs MPLN Comparison
APLT vs MPLN Comparison
Compare APLT & MPLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- MPLN
- Stock Information
- Founded
- APLT 2016
- MPLN 1980
- Country
- APLT United States
- MPLN United States
- Employees
- APLT N/A
- MPLN N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- MPLN Business Services
- Sector
- APLT Health Care
- MPLN Consumer Discretionary
- Exchange
- APLT Nasdaq
- MPLN Nasdaq
- Market Cap
- APLT 140.8M
- MPLN 113.4M
- IPO Year
- APLT 2019
- MPLN N/A
- Fundamental
- Price
- APLT $1.10
- MPLN $7.06
- Analyst Decision
- APLT Buy
- MPLN Hold
- Analyst Count
- APLT 6
- MPLN 2
- Target Price
- APLT $6.60
- MPLN $25.00
- AVG Volume (30 Days)
- APLT 10.8M
- MPLN 67.1K
- Earning Date
- APLT 11-07-2024
- MPLN 11-05-2024
- Dividend Yield
- APLT N/A
- MPLN N/A
- EPS Growth
- APLT N/A
- MPLN N/A
- EPS
- APLT N/A
- MPLN N/A
- Revenue
- APLT N/A
- MPLN $942,614,000.00
- Revenue This Year
- APLT N/A
- MPLN N/A
- Revenue Next Year
- APLT $5,117.00
- MPLN $1.17
- P/E Ratio
- APLT N/A
- MPLN N/A
- Revenue Growth
- APLT N/A
- MPLN N/A
- 52 Week Low
- APLT $1.03
- MPLN $4.80
- 52 Week High
- APLT $10.62
- MPLN $69.20
- Technical
- Relative Strength Index (RSI)
- APLT 17.64
- MPLN 45.34
- Support Level
- APLT $1.03
- MPLN $6.64
- Resistance Level
- APLT $1.37
- MPLN $7.89
- Average True Range (ATR)
- APLT 0.33
- MPLN 0.69
- MACD
- APLT -0.15
- MPLN 0.09
- Stochastic Oscillator
- APLT 0.75
- MPLN 41.28
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About MPLN MultiPlan Corporation
MultiPlan Corp is a provider of data analytics and technology-enabled solutions designed to bring affordability, efficiency, and fairness to the U.S. healthcare industry. The company interprets clients' needs and customizes solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry.